摘要
目的探讨健肌宁治疗重症肌无力(脾肾亏虚证)的临床疗效。方法将患者随机分为两组,对照组用强的松或嗅吡斯的明治疗;实验组采用健肌宁颗粒联合基础西药(强的松或嗅吡斯的明)治疗;根据入组时及用药后第1、3、6个月3个阶段,采用重症肌无力定量评分(QMG)进行疗效评价。结果所有患者经治疗后均有效,实验组治疗3个月及6个月后总有效率均高于对照组。结论健肌宁联合西药对重症肌无力(脾肾亏虚证)的干预作用疗效确定,在6个月后更为显著。
Objective： To investigate the interventional effect of Jianji Ning Granule on the myasthenia gravis （MG） patients with spleen-kidney deficiency type. Methods： Patients were randomly divided into two groups. Control group were treated with basic western medicine （prednisone or olfactory pyridostigmine）, while experimental group were treated with basic western medicine combined with Chinese medicine. The efficacy was compared and the Quantitative score of myasthenia gravis （QMG） was measured before and after treatment 1,3,6 months. Results： After treatment all the patients were improved,while the total effective rate after 3 and 6 months in the experimental group were significantly higher than those in the control groups. Conclusion： Therapy with Jianji Ning Granule combined with Western medicine shows definite effects in treating MG patients with spleen-kidney deficiency type,especially shows more significantly after 6 months.
出处
《中国中医急症》
2013年第5期712-713,742,共3页
Journal of Emergency in Traditional Chinese Medicine
基金
上海市科委基础研究重点项目(10JC1414500)
上海市卫生局中医药科研基金计划项目(2010J002B)
关键词
重症肌无力
健肌宁
脾肾亏虚
研究
Myasthenia gravis
Jianjining Granule
Spleen -kidney deficiency
Research
